Residual lung abnormalities were consistent with elevated epithelial injury biomarkers, profibrotic signaling.

Judges milled about the artificial turf to listen to Central High School's young scientists present their research projects, ...

PhotonPharma Inc., a biopharmaceutical company pioneering personalized cancer immunotherapies, today announced that patient recruitment has opened for its Phase 1 clinical trial evaluating Innocell™ ...

Breast cancer (BC) is the most common cancer and the second leading cause of cancer death in women. It is a highly variable ...

Researchers have created a comprehensive single-cell atlas of the human breast, which uncovers diverse cell types linked to ...

There’s currently no reliable screening test for ovarian cancer, meaning that most cases are caught at an advanced stage, ...

OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...

1. Park K-W, Choi B, Moon D-H, Park S-M, Ye Y-M. Serum haptoglobin as a predictor of treatment response in patients with chronic spontaneous urticaria. Clin Trans Allergy. Published online January 7, ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, ...

Preclinical study findings point to new possibilities for strategies for treating metastatic TNBC patients for whom there are no specific therapies.

A new study by cell biologists at the University of California, Santa Cruz, suggests that an early first pregnancy may ...